BP-C1

N/A

Report date: 2024/07/10 11:07:58
NME

Base Information

Drug NameBP-C1
Drug Alias NameBP-C1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA cross linking agentsApoptosis stimulantsDNA synthesis inhibitors
TargetsDNA
Therapy Area/IndicationsMetastatic breast cancerPancreatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanThailandRussian Federation +[6] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMeabco As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeabco As
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerPancreatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A